ARCHIVES

Center Review By Panel, NCI Leading To Changes; Hammer Tells NCAB It Faces “Difficult Decision”

This article is from The Cancer Letter archive.

Vol. 10 No. 48 | December 13, 1984

Download PDF Visit The Full Archive

Related Articles

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

June 20, 1975

Youth Smoking Begins To Decline, NCI Says

April 5, 2002

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

Studies Seek to Identify High-Risk Groups to Justify Mammography Screening at 40

May 4, 2012

In Brief: Hatch Introduces Bill Banning Smoking On U.S. Public Conveyances; New OCC Staff Announced

January 16, 1987

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

August 12, 2011